Literature DB >> 9786450

The IGF family and folliculogenesis.

E Y Adashi1.   

Abstract

The process of ovarian follicular development is a long and arduous one, marked by dramatic proliferation and differentiation of both the somatic and germ cell elements. To a large extent, this explosive agenda is under the control of conventional endocrine principles, involving hormones such as pituitary gonadotropins and ovarian steroids. Importantly, it has become increasingly apparent that several phenomena central to ovarian physiology are not fully accounted for by conventional endocrine principles. As an example, consideration must be given to the process of follicular selection whereby a predetermined number of follicle(s) is recruited, selected, allowed to assert dominance, and ultimately ovulate despite the fact that all follicles are afforded comparable gonadotropic stimulation. These observations have given rise to the suggestion that the regulation of ovarian function may be under the control of yet another group of modulatory principles known under the general term 'putative intra-ovarian regulators'. It is generally envisioned that the exquisitely-timed and highly-regionalized expression of these locally-derived, often peptidergic, principles may finally account for those aspects of the ovarian life cycle which at this time defy conventional explanation. It has been hypothesized that the role of IGF-1 in the context of ovarian physiology is to serve as an amplifier of gonadotropin hormonal action. At this time, significant support for this hypothesis can be documented. More speculative is the notion that IGF-1 may partake in intrafollicular intercompartmental coordination, a concept presupposing enhanced more coordinated follicular development, due to granulosa-theca-interstitial cell cross-talk and improved coupling. Entirely in the speculative realm is the proposition that IGF-1 may in fact partake in the process of follicular selection, a notion for which relatively limited support can be derived at this time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786450     DOI: 10.1016/s0165-0378(98)00026-6

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  12 in total

1.  Female Fertility: It Takes Two to Tango.

Authors:  Lucy X Chen; Patricia T Jimenez
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 2.  microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Authors:  Claudio Pulito; Sara Donzelli; Paola Muti; Luisa Puzzo; Sabrina Strano; Giovanni Blandino
Journal:  Ann Transl Med       Date:  2014-06

Review 3.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

4.  Putative role of the phosphatidylinositol 3-kinase-Akt signaling pathway in the survival of granulosa cells.

Authors:  S D Westfall; I R Hendry; K L Obholz; B R Rueda; J S Davis
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

5.  Among high responders, is oocyte development potential different in Rotterdam consensus PCOS vs non-PCOS patients undergoing IVF?

Authors:  Veronique Bellemare; Keren Rotshenker-Olshinka; Laura Nicholls; Alyson Digby; Amrita Pooni; Einav Kadour-Peero; Weon-Young Son; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2022-08-27       Impact factor: 3.357

6.  Estradiol and luteinizing hormone regulation of insulin-like growth factor binding protein production by bovine granulosa and thecal cells.

Authors:  Leon J Spicer; Connie S Chamberlain
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

Review 7.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

8.  Androgens promote the acquisition of maturation competence in bovine oocytes.

Authors:  Miho Makita; Takashi Miyano
Journal:  J Reprod Dev       Date:  2015-03-07       Impact factor: 2.214

9.  Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention.

Authors:  Claudio Pulito; Toran Sanli; Punam Rana; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Metabolites       Date:  2013-11-07

10.  Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective.

Authors:  Luca Narduzzi; Corinne Buisson; Marie-Line Morvan; Alexandre Marchand; Michel Audran; Yves Le Bouc; Emmanuelle Varlet-Marie; Magnus Ericsson; Bruno Le Bizec; Gaud Dervilly
Journal:  Front Mol Biosci       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.